Effect of acute topical application of (+)-pentazocine on the mechanical allodynia in diabetic mice

European Journal of Pharmacology

Volumn 641, Issue 1, 2010, Pages 49-53

  Ohsawa, Masahiro ^a   Hayashi, Shun suke ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

(Diabetic mice); Anti allodynia; Nitric oxide (NO); Sensory nerve; Sigma receptor

Indexed keywords

N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; NITRIC OXIDE; NORBINALTORPHIMINE; PENTAZOCINE; SIGMA RECEPTOR LIGAND; STREPTOZOCIN; ETHYLENEDIAMINE DERIVATIVE; KAPPA OPIATE RECEPTOR; NALTREXONE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HINDLIMB; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DIABETES COMPLICATIONS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; DIABETES COMPLICATIONS; ETHYLENEDIAMINES; MALE; MICE; MICE, INBRED ICR; NALTREXONE; NITRIC OXIDE; PENTAZOCINE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, SIGMA;

EID: 77953810756     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.005     Document Type: Article

References (37)

1. Ahlgren S.C., Levine J.D. Protein kinase C inhibitors decrease hyperalgesia and C-fibre hyperexcitability in the streptozotocin-diabetic rat. J. Neurophysiol. 1994, 72:684-692.
2. Aley K.O., McCarter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 1998, 18:7008-7014.
3. Beirith A., Santos A.R., Calixto J.B. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res. 2002, 924:219-228.
4. Bhardwaj A., Sawada M., London E.D., Koehler R.C., Traystman R.J., Kirsch J.R. Potent (4-phenylbutyl) piperidine modulates basal and N-methyl-d-aspartate-evoked nitric oxide production in vivo. Stroke 1998, 29:2404-2411.
5. Bojunga J., Dresar-Mayert B., Usadel K.H., Kusterer K., Zeuzem S. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Biochem. Biophys. Res. Commun. 2004, 316:771-780.
6. Carrington A.L., Litchfield J.E. The aldose reductase pathway and nonenzymatic glycation in the pathogenesis of diabetic neuropathy: a critical review for the end of the 20th Century. Diab. Rev. 1999, 7:275-299.
7. Chu Y.C., Guan Y., Skinner J., Raja S.N., Johns R.A., Tao Y.X. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 2005, 119:113-123.
8. Costa B., Colleoni M., Conti S., Trovato A.E., Bianchi M., Sotgiu M.L., Giagnoni G. Repeated treatment with the synthetic cannabinoid WIN 55, 212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br. J. Pharmacol. 2004, 141:4-8.
9. Goyagi T., Goto S., Bhardwaj A., Dawson V.L., Hurn P.D., Kirsch J.R. Neuroprotective effect of σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine is linked to reduced neuronal nitric oxide production. Stroke 2001, 32:1613-1620.
10. Greene D.A., Stevens M.J., Obrosova I., Feldman E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur. J. Pharmacol. 1999, 375:217-223.
11. Gundlach A.L., Largent B.L., Snyder S.H. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 1986, 6:1757-1770.
12. ++ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons. J. Pharmacol. Exp. Ther. 1995, 275:207-214.
13. Hellewell S.B., Bowen W.D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 1990, 527:244-253.
14. Holthusen H. Involvement of the NO/cyclic GMP pathway in bradykinin-evoked pain from veins in humans. Pain 1997, 69:87-92.
15. Holthusen H., Arndt J.O. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett. 1994, 165:71-74.
16. Holthusen H., Arndt J.O. Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J. Physiol. 1995, 487:253-258.
17. Hong S., Morrow T.J., Paulson P.E., Isom L.L., Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 2004, 279:29341-29350.
18. Inoue M., Shimohira I., Yoshida A., Zimmer A., Takeshima H., Sakurada T., Ueda H. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J. Pharmacol. Exp. Ther. 1999, 291:308-313.
19. Jagodic M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksovic P.M., Rosenberg E.R., Bayliss D.A., Jevtovic-Todorovic V., Todorovic S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J. Neurosci. 2007, 27:3305-3316.
20. Kamei J., Iwamoto Y., Misawa M., Nagase H., Kasuya Y. Antinociceptive effect of l-arginine in diabetic mice. Eur. J. Pharmacol. 1994, 254:113-117.
21. Kamei J., Tamura N., Saitoh A. Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice. Pain 2005, 117:112-120.
22. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 1996, 229:553-558.
23. Mardon K., Kassiou M., Donald A. Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain. Life Sci. 1999, 65:PL281-PL286.
24. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 1994, 266:E829-E839.
25. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
26. Ohsawa M., Kamei J. Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 1998, 372:221-228.
27. Omote K., Hazama K., Kawamata T., Kawamata M., Nakayaka Y., Toriyabe M., Namiki A. Peripheral nitric oxide in carrageenan-induced inflammation. Brain Res. 2001, 912:171-175.
28. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., Malan T.P. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 2003, 99:955-960.
29. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13:85-86.
30. Tomlinson D.R., Fernyhough P., Diemel L.T. Neurotropins and peripheral neuropathy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1996, 351:455-462.
31. Ueda H., Inoue M., Yoshida A., Mizuno K., Yamamoto H., Maruo J., Matsuno K., Mita S. Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice. J. Pharmacol. Exp. Ther. 2001, 298:703-710.
32. Vagnerova K., Hurn P.D., Bhardwaj A., Kirsch J.R. Sigma 1 receptor agonists act as neuroprotective drugs through inhibition of inducible nitric oxide synthase. Anesth. Analg. 2006, 103:430-434.
33. Vareniuk I., Pavlov I.A., Obrosova I.G. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 2008, 51:2126-2133.
34. Vinik A.I., Park T.S., Stansberry K., Pittenger G.L. Diabetic neuropathies. Diabetologia 2000, 43:957-973.
35. Vlassara H., Brownlee M., Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:5190-5192.
36. Watkins C.C., Sawa A., Jaffrey S., Blackshaw S., Barrow R.K., Snyder S.H., Ferris C.D. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J. Clin. Invest. 2000, 106:373-384.
37. Zhang H., Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J. Neurophysiol. 2002, 87:2867-2879.